{"id":"W3140874869","doi":"","title":"III.白血球系 5.Hyper eosinophic syndrome(HES)の病態と新たな治療:imatinib療法と抗IL-5抗体療法","year":2005,"lang":"ja","type":"article","venue":"Canadian parliamentary review","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Imatinib; Cancer research; Medicine; Internal medicine; Endocrinology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001647876,0.0005324579,0.000832616,0.002122005,0.001119692,0.001195802,0.001113584,0.002917499,0.004991422],"category_scores_gemma":[0.002685484,0.0002455445,0.0005884082,0.001809444,0.001695586,0.001039935,0.0008058474,0.002528926,0.002443105],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00700356,"about_ca_system_score_gemma":0.01088074,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1056361,"about_ca_topic_score_gemma":0.2028915,"domain_scores_codex":[0.9993291,0.00007454239,0.00009748909,0.00004907041,0.0003016239,0.0001482796],"domain_scores_gemma":[0.9987808,0.0002555106,0.0001493435,0.00002925676,0.0006764229,0.0001087065],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001679131,0.00002468077,0.0005657856,0.00505548,0.00004595943,0.001417393,0.0001446449,0.0001533213,0.00107518,0.01009239,0.667389,0.3138683],"study_design_scores_gemma":[0.00001693597,0.00001542327,0.0009656552,0.001333637,0.00003060469,0.0008843596,0.00006611616,0.00001327475,0.0001623187,0.0005224065,0.9959794,0.000009832268],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.0003178396,0.9349647,0.0002032391,0.03077802,0.02158935,0.0000293098,0.0001105748,0.00001548811,0.01199143],"genre_scores_gemma":[0.006656172,0.8935267,0.0006123421,0.05189706,0.01624493,0.00006622045,0.0001928709,0.00001622523,0.0307875],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.1056361,"threshold_uncertainty_score":0.2100425,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02048793319267121,"score_gpt":0.264721325767401,"score_spread":0.2442333925747298,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}